The most common cause of fungal meningitis for people with weak immune systems is Cryptococcus. This study aims to investigate the involvement of the autophagy protein 7 in the physiology and pathogenic potential of Cryptococcus neoformans.
Even in the era of antiretroviral treatment, mucosal candidiasis remains one of the most common manifestations in HIV-infected subjects. This editorial discusses the loss of immune control that allows mucosal candidiasis to occur.
In this review the authors look into the potential use of pharmacogenomics in predisposing ribavirin-treated hepatitis C patients to anemia.
This study evaluates the direct high-throughput multiple genetic detection system for H. pylori in gastric biopsy samples. Could this method efficiently diagnose and quantify H. pylori burden? And does it have the capacity to screen for virulence, antibiotic resistance and multistrain infections?
In this review the author looks at the progress of vaccine development towards mosquito-borne viral diseases, such as Zika and chikungunya.
Could probiotics be used to treat Enterotoxigenic Escherichia coli (ETEC)? This review discusses ETEC pathogenesis, its modulation by human gastrointestinal cues and novel preventive strategies such as probiotics.
In this study the authors delve into fighting antibiotic resistance, aiming to synthesize and evaluate the antimicrobial activity of a new series of quinazolinone azolyl ethanols .
This editorial discusses the role of metabolomics in identifying TB biomarkers, which have shed light on previously unknown disease mechanisms and could contribute to improved TB diagnostics.
Could one vaccine dose be as effective as two or three doses at preventing persistent HPV infection in the cervix in young women? This review discusses HPV vaccine coverage and the possibility of a one-dose schedule.
This perspective discusses the urgent need for novel and efficient antimicrobial strategies against C. difficile and the authors evaluate the application of the acyldepsipeptides family of antibiotics to treat C. difficile infections.